457P 1st-line panitumumab plus FOLFIRI or FOLFOX for patients with RAS wildtype metastatic colorectal cancer in Germany: Interim results of the non-interventional study VALIDATE

Autor: Uhlig, J., Potenberg, J., Semsek, D., Stübs, P., Fichter, C.D., Köhler, A., Müller, L., Reiser, M., Siebenbach, H.U., Göhler, T., Jacobasch, L., Kächele, V., Timm, B., Potthoff, K., Marschner, N.W.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S436-S436
Databáze: ScienceDirect